Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
940K
-
Shares change
-
+86.4K
-
Total reported value, excl. options
-
$148M
-
Value change
-
+$13M
-
Number of buys
-
36
-
Number of sells
-
-44
-
Price
-
$156.97
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q4 2024
125 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q4 2024.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 940K shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (122K shares), Miller Investment Management, LP (92.2K shares), MORGAN STANLEY (91.6K shares), BANK OF AMERICA CORP /DE/ (86.5K shares), WELLS FARGO & COMPANY/MN (75.8K shares), TD Waterhouse Canada Inc. (63.6K shares), COMMONWEALTH EQUITY SERVICES, LLC (30.4K shares), UBS Group AG (27.8K shares), LPL Financial LLC (24.7K shares), and RAYMOND JAMES FINANCIAL INC (21.5K shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.